Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kimberly Pelak is active.

Publication


Featured researches published by Kimberly Pelak.


PLOS Genetics | 2010

The Characterization of Twenty Sequenced Human Genomes

Kimberly Pelak; Dongliang Ge; Jessica M. Maia; Mingfu Zhu; Jason P. Smith; Elizabeth T. Cirulli; Jacques Fellay; Samuel P. Dickson; Curtis Gumbs; Erin L. Heinzen; Anna C. Need; Elizabeth K. Ruzzo; Abanish Singh; C. Ryan Campbell; Linda K. Hong; Katharina A. Lornsen; Alexander McKenzie; Nara Sobreira; Julie Hoover-Fong; Joshua D. Milner; Ruth Ottman; Barton F. Haynes; James J. Goedert; David B. Goldstein

We present the analysis of twenty human genomes to evaluate the prospects for identifying rare functional variants that contribute to a phenotype of interest. We sequenced at high coverage ten “case” genomes from individuals with severe hemophilia A and ten “control” genomes. We summarize the number of genetic variants emerging from a study of this magnitude, and provide a proof of concept for the identification of rare and highly-penetrant functional variants by confirming that the cause of hemophilia A is easily recognizable in this data set. We also show that the number of novel single nucleotide variants (SNVs) discovered per genome seems to stabilize at about 144,000 new variants per genome, after the first 15 individuals have been sequenced. Finally, we find that, on average, each genome carries 165 homozygous protein-truncating or stop loss variants in genes representing a diverse set of pathways.


The Journal of Infectious Diseases | 2010

Host Determinants of HIV-1 Control in African Americans

Kimberly Pelak; David B. Goldstein; Nicole M. Walley; Jacques Fellay; Dongliang Ge; Curtis Gumbs; Xiaojiang Gao; Jessica M. Maia; Kenneth D. Cronin; Shehnaz K. Hussain; Mary Carrington; Nelson L. Michael; Amy C. Weintrob

We performed a whole-genome association study of human immunodeficiency virus type 1 (HIV-1) set point among a cohort of African Americans (n = 515), and an intronic single-nucleotide polymorphism (SNP) in the HLA-B gene showed one of the strongest associations. We use a subset of patients to demonstrate that this SNP reflects the effect of the HLA-B*5703 allele, which shows a genome-wide statistically significant association with viral load set point (P = 5.6 x 10(-10)). These analyses therefore confirm a member of the HLA-B*57 group of alleles as the most important common variant that influences viral load variation in African Americans, which is consistent with what has been observed for individuals of European ancestry, among whom the most important common variant is HLA-B*5701.


PLOS Biology | 2011

Copy number variation of KIR genes influences HIV-1 control

Kimberly Pelak; Anna C. Need; Jacques Fellay; Sheng Feng; Thomas J. Urban; Dongliang Ge; Andrea De Luca; Javier Martinez-Picado; Steven M. Wolinsky; Jeremy J. Martinson; Beth D. Jamieson; Jay H. Bream; Maureen P. Martin; Persephone Borrow; Norman L. Letvin; Andrew J. McMichael; Barton F. Haynes; Amalio Telenti; Mary Carrington; David B. Goldstein; Galit Alter

The authors that the number of activating and inhibitory KIR genes varies between individuals and plays a role in the regulation of immune mechanisms that determine HIV-1 control.


Nature Medicine | 2009

CCL3L1 and HIV/AIDS susceptibility.

Thomas J. Urban; Amy C. Weintrob; Jacques Fellay; Sara Colombo; Curtis Gumbs; Margalida Rotger; Kimberly Pelak; Kristen K. Dang; Roger Detels; Jeremy J. Martinson; Stephen J. O'Brien; Norman L. Letvin; Andrew J. McMichael; Barton F. Haynes; Mary Carrington; Amalio Telenti; Nelson L. Michael; David B. Goldstein

Keywords: Gene Dosage Note: Letter / Comment in: Nat Med. 2009 Oct;15(10):1112-5 and Nat Med. 2009 Oct;15(10):1127-9 and Nat Med. 2009 Oct;15(10):1117-20 / Comment on: Nat Med. 2008 Apr;14(4):413-20 Reference EPFL-ARTICLE-165167doi:10.1038/nm1009-1110 Record created on 2011-04-19, modified on 2016-08-09


American Journal of Human Genetics | 2012

Mutation in TECPR2 Reveals a Role for Autophagy in Hereditary Spastic Paraparesis

Danit Oz-Levi; Bruria Ben-Zeev; Elizabeth K. Ruzzo; Yuki Hitomi; Amir Gelman; Kimberly Pelak; Yair Anikster; Haike Reznik-Wolf; Ifat Bar-Joseph; Tsviya Olender; Anna Alkelai; Meira Weiss; Edna Ben-Asher; Dongliang Ge; Zvulun Elazar; David B. Goldstein; Elon Pras; Doron Lancet

We studied five individuals from three Jewish Bukharian families affected by an apparently autosomal-recessive form of hereditary spastic paraparesis accompanied by severe intellectual disability, fluctuating central hypoventilation, gastresophageal reflux disease, wake apnea, areflexia, and unique dysmorphic features. Exome sequencing identified one homozygous variant shared among all affected individuals and absent in controls: a 1 bp frameshift TECPR2 deletion leading to a premature stop codon and predicting significant degradation of the protein. TECPR2 has been reported as a positive regulator of autophagy. We thus examined the autophagy-related fate of two key autophagic proteins, SQSTM1 (p62) and MAP1LC3B (LC3), in skin fibroblasts of an affected individual, as compared to a healthy control, and found that both protein levels were decreased and that there was a more pronounced decrease in the lipidated form of LC3 (LC3II). siRNA knockdown of TECPR2 showed similar changes, consistent with aberrant autophagy. Our results are strengthened by the fact that autophagy dysfunction has been implicated in a number of other neurodegenerative diseases. The discovered TECPR2 mutation implicates autophagy, a central intracellular mechanism, in spastic paraparesis.


Bioinformatics | 2011

SVA: software for annotating and visualizing sequenced human genomes

Dongliang Ge; Elizabeth K. Ruzzo; Min He; Kimberly Pelak; Erin L. Heinzen; Anna C. Need; Elizabeth T. Cirulli; Jessica M. Maia; Samuel P. Dickson; Mingfu Zhu; Abanish Singh; Andrew S. Allen; David B. Goldstein

Summary: Here we present Sequence Variant Analyzer (SVA), a software tool that assigns a predicted biological function to variants identified in next-generation sequencing studies and provides a browser to visualize the variants in their genomic contexts. SVA also provides for flexible interaction with software implementing variant association tests allowing users to consider both the bioinformatic annotation of identified variants and the strength of their associations with studied traits. We illustrate the annotation features of SVA using two simple examples of sequenced genomes that harbor Mendelian mutations. Availability and implementation: Freely available on the web at http://www.svaproject.org. Contact: [email protected] Supplementary information: Supplementary data are available at Bioinformatics online.


American Journal of Human Genetics | 2012

Using ERDS to infer copy-number variants in high-coverage genomes.

Mingfu Zhu; Anna C. Need; Yujun Han; Dongliang Ge; Jessica M. Maia; Qianqian Zhu; Erin L. Heinzen; Elizabeth T. Cirulli; Kimberly Pelak; Min He; Elizabeth K. Ruzzo; Curtis Gumbs; Abanish Singh; Sheng Feng; David B. Goldstein

Although there are many methods available for inferring copy-number variants (CNVs) from next-generation sequence data, there remains a need for a system that is computationally efficient but that retains good sensitivity and specificity across all types of CNVs. Here, we introduce a new method, estimation by read depth with single-nucleotide variants (ERDS), and use various approaches to compare its performance to other methods. We found that for common CNVs and high-coverage genomes, ERDS performs as well as the best method currently available (Genome STRiP), whereas for rare CNVs and high-coverage genomes, ERDS performs better than any available method. Importantly, ERDS accommodates both unique and highly amplified regions of the genome and does so without requiring separate alignments for calling CNVs and other variants. These comparisons show that for genomes sequenced at high coverage, ERDS provides a computationally convenient method that calls CNVs as well as or better than any currently available method.


Human Molecular Genetics | 2012

Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans

Paul J. McLaren; Stephan Ripke; Kimberly Pelak; Amy C. Weintrob; Nikolaos A. Patsopoulos; Xiaoming Jia; Rachel L. Erlich; Niall J. Lennon; Carl M. Kadie; David Heckerman; Namrata Gupta; David W. Haas; Steven G. Deeks; Florencia Pereyra; Bruce D. Walker; Paul I. W. de Bakker

A small proportion of human immunodeficiency virus-1 (HIV-1) infected individuals, termed HIV-1 controllers, suppress viral replication to very low levels in the absence of therapy. Genetic investigations of this phenotype have strongly implicated variation in the class I major histocompatibility complex (MHC) region as key to HIV-1 control. We collected sequence-based classical class I HLA genotypes at 4-digit resolution in HIV-1-infected African American controllers and progressors (n = 1107), and tested them for association with host control using genome-wide single nucleotide polymorphism data to account for population structure. Several classical alleles at HLA-B were associated with host control, including B*57:03 [odds ratio (OR) = 5.1; P= 3.4 × 10(-18)] and B*81:01 (OR = 4.8; P= 1.3 × 10(-9)). Analysis of variable amino acid positions demonstrates that HLA-B position 97 is the most significant association with host control in African Americans (omnibus P = 1.2 × 10(-21)) and explains the signal of several HLA-B alleles, including B*57:03. Within HLA-B, we also identified independent effects at position 116 (omnibus P= 2.8 × 10(-15)) in the canonical F pocket, position 63 in the B pocket (P= 1.5 × 10(-3)) and the non-pocket position 245 (P= 8.8 × 10(-10)), which is thought to influence CD8-binding kinetics. Adjusting for these HLA-B effects, there is evidence for residual association in the MHC region. These results underscore the key role of HLA-B in affecting HIV-1 replication, likely through the molecular interaction between HLA-B and viral peptides presented by infected cells, and suggest that sites outside the peptide-binding pocket also influence HIV-1 control.


Neuron | 2013

Deficiency of asparagine synthetase causes congenital microcephaly and a progressive form of encephalopathy

Elizabeth K. Ruzzo; José-Mario Capo-Chichi; Bruria Ben-Zeev; David Chitayat; Hanqian Mao; Andrea L. Pappas; Yuki Hitomi; Yi-Fan Lu; Xiaodi Yao; Fadi F. Hamdan; Kimberly Pelak; Haike Reznik-Wolf; Ifat Bar-Joseph; Danit Oz-Levi; Dorit Lev; Tally Lerman-Sagie; Esther Leshinsky-Silver; Yair Anikster; Edna Ben-Asher; Tsviya Olender; Laurence Colleaux; Jean-Claude Décarie; Susan Blaser; Brenda Banwell; Rasesh B. Joshi; Xiao-Ping He; Lysanne Patry; Rachel Silver; Mohammad Safiqul Islam; Abul Hasnat

We analyzed four families that presented with a similar condition characterized by congenital microcephaly, intellectual disability, progressive cerebral atrophy, and intractable seizures. We show that recessive mutations in the ASNS gene are responsible for this syndrome. Two of the identified missense mutations dramatically reduce ASNS protein abundance, suggesting that the mutations cause loss of function. Hypomorphic Asns mutant mice have structural brain abnormalities, including enlarged ventricles and reduced cortical thickness, and show deficits in learning and memory mimicking aspects of the patient phenotype. ASNS encodes asparagine synthetase, which catalyzes the synthesis of asparagine from glutamine and aspartate. The neurological impairment resulting from ASNS deficiency may be explained by asparagine depletion in the brain or by accumulation of aspartate/glutamate leading to enhanced excitability and neuronal damage. Our study thus indicates that asparagine synthesis is essential for the development and function of the brain but not for that of other organs.


Human Molecular Genetics | 2013

A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A

Jérôme Lane; Paul J. McLaren; Lucy Dorrell; Amanda Stemke; Kimberly Pelak; Stephen Moore; Johannes Oldenburg; Maria Teresa Alvarez-Roman; Anne Angelillo-Scherrer; Françoise Boehlen; Paula H. B. Bolton-Maggs; Brigit Brand; Deborah Brown; Elaine Y. Chiang; Ana Rosa Cid-Haro; Bonaventura Clotet; Peter William Collins; Sara Colombo; Judith Dalmau; Patrick F. Fogarty; Paul Giangrande; A. Gringeri; Rathi V. Iyer; Olga Katsarou; Christine L. Kempton; Philip Kuriakose; Judith Lin; M. Makris; Marilyn J. Manco-Johnson; Dimitrios A. Tsakiris

Human genetic variation contributes to differences in susceptibility to HIV-1 infection. To search for novel host resistance factors, we performed a genome-wide association study (GWAS) in hemophilia patients highly exposed to potentially contaminated factor VIII infusions. Individuals with hemophilia A and a documented history of factor VIII infusions before the introduction of viral inactivation procedures (1979-1984) were recruited from 36 hemophilia treatment centers (HTCs), and their genome-wide genetic variants were compared with those from matched HIV-infected individuals. Homozygous carriers of known CCR5 resistance mutations were excluded. Single nucleotide polymorphisms (SNPs) and inferred copy number variants (CNVs) were tested using logistic regression. In addition, we performed a pathway enrichment analysis, a heritability analysis, and a search for epistatic interactions with CCR5 Δ32 heterozygosity. A total of 560 HIV-uninfected cases were recruited: 36 (6.4%) were homozygous for CCR5 Δ32 or m303. After quality control and SNP imputation, we tested 1 081 435 SNPs and 3686 CNVs for association with HIV-1 serostatus in 431 cases and 765 HIV-infected controls. No SNP or CNV reached genome-wide significance. The additional analyses did not reveal any strong genetic effect. Highly exposed, yet uninfected hemophiliacs form an ideal study group to investigate host resistance factors. Using a genome-wide approach, we did not detect any significant associations between SNPs and HIV-1 susceptibility, indicating that common genetic variants of major effect are unlikely to explain the observed resistance phenotype in this population.

Collaboration


Dive into the Kimberly Pelak's collaboration.

Top Co-Authors

Avatar

David B. Goldstein

Columbia University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna C. Need

Imperial College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jacques Fellay

École Polytechnique Fédérale de Lausanne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Curtis Gumbs

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge